Prudential PLC decreased its holdings in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 15.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,187 shares of the medical equipment provider’s stock after selling 920 shares during the quarter. Prudential PLC’s holdings in Align Technology were worth $1,421,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. EFG Asset Management Americas Corp. raised its position in shares of Align Technology by 3.6% in the 4th quarter. EFG Asset Management Americas Corp. now owns 1,167 shares of the medical equipment provider’s stock valued at $320,000 after purchasing an additional 41 shares in the last quarter. Dfpg Investments LLC raised its holdings in Align Technology by 3.3% in the fourth quarter. Dfpg Investments LLC now owns 1,327 shares of the medical equipment provider’s stock valued at $340,000 after acquiring an additional 42 shares in the last quarter. Richard W. Paul & Associates LLC boosted its stake in Align Technology by 2.8% during the 4th quarter. Richard W. Paul & Associates LLC now owns 1,669 shares of the medical equipment provider’s stock valued at $457,000 after acquiring an additional 45 shares during the last quarter. Valley National Advisers Inc. grew its holdings in Align Technology by 29.7% during the 3rd quarter. Valley National Advisers Inc. now owns 214 shares of the medical equipment provider’s stock worth $65,000 after acquiring an additional 49 shares in the last quarter. Finally, Jag Capital Management LLC raised its stake in shares of Align Technology by 4.1% in the 3rd quarter. Jag Capital Management LLC now owns 1,258 shares of the medical equipment provider’s stock valued at $384,000 after purchasing an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 88.43% of the company’s stock.
Align Technology Stock Up 0.1 %
ALGN stock opened at $255.70 on Tuesday. The firm’s 50-day simple moving average is $285.11 and its 200 day simple moving average is $281.23. The stock has a market cap of $19.25 billion, a PE ratio of 42.13, a price-to-earnings-growth ratio of 4.68 and a beta of 1.62. Align Technology, Inc. has a fifty-two week low of $176.34 and a fifty-two week high of $413.20.
Align Technology (NASDAQ:ALGN – Get Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The medical equipment provider reported $1.62 EPS for the quarter, beating the consensus estimate of $1.54 by $0.08. The company had revenue of $997.43 million for the quarter, compared to analyst estimates of $971.97 million. Align Technology had a net margin of 11.80% and a return on equity of 14.15%. Equities analysts forecast that Align Technology, Inc. will post 7.95 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on ALGN shares. SVB Leerink began coverage on Align Technology in a research note on Monday, February 26th. They issued a “market perform” rating and a $310.00 price target for the company. Evercore ISI decreased their target price on Align Technology from $370.00 to $300.00 and set an “outperform” rating for the company in a research report on Monday. Leerink Partnrs reissued a “market perform” rating on shares of Align Technology in a research report on Monday, February 26th. Morgan Stanley raised their price objective on Align Technology from $344.00 to $360.00 and gave the stock an “overweight” rating in a research note on Thursday, April 25th. Finally, Robert W. Baird boosted their target price on shares of Align Technology from $333.00 to $370.00 and gave the company an “outperform” rating in a research note on Thursday, April 25th. One research analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $351.00.
Read Our Latest Analysis on ALGN
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Featured Stories
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).
Receive News & Ratings for Align Technology Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Align Technology and related companies with MarketBeat.com’s FREE daily email newsletter.